1. Ocular Therapeutix Inc.
2. Portola Pharmaceuticals Inc.
3. Alcon
4. Santen Pharmaceutical Co. Ltd.
5. Novartis
Published | Pages | Publisher | Report code |
---|---|---|---|
Feb 2022 | 195 | Renub Research | ASDR-597014 |
1. Ocular Therapeutix Inc.
2. Portola Pharmaceuticals Inc.
3. Alcon
4. Santen Pharmaceutical Co. Ltd.
5. Novartis